Nanoparticle applications in ocular gene therapy

  title={Nanoparticle applications in ocular gene therapy},
  author={Xue Cai and Shannon M Conley and M. Naash},
  journal={Vision Research},
  • Xue Cai, Shannon M Conley, M. Naash
  • Published 2008
  • Medicine, Psychology
  • Vision Research
  • The use of nanoparticles as carriers for the delivery of therapeutic materials to target tissues has became popular in recent years and has demonstrated great potentials for the treatments of a wide range of diseases. In this review, we summarize the advantages of nanotechnology as a common gene delivery strategy with emphasis on ocular therapy. Particular attention is paid to the CK30-PEG compacted DNA nanoparticles that have been successfully tested in the eye, lung, and brain. These… CONTINUE READING

    Topics from this paper.

    Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
    • 494
    • Open Access
    Drug delivery systems: Advanced technologies potentially applicable in personalized treatments
    • 180
    • Highly Influenced
    • Open Access
    Nanocarriers in ocular drug delivery: an update review.
    • 116
    Chitosan nanoparticles for drug delivery to the eye
    • 80
    Gene therapy in the Cornea: 2005–present
    • 58
    • Open Access


    Publications referenced by this paper.
    Progress and problems with the use of viral vectors for gene therapy
    • 1,964
    • Open Access
    Regulated portals of entry into the cell
    • 3,223
    • Open Access
    Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
    • 180
    • Open Access
    Targeting of nanoparticles to the clathrin-mediated endocytic pathway.
    • 443
    Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
    • 292
    • Open Access
    Gene therapy progress and prospects: the eye
    • 156
    • Open Access
    Nanoparticles for gene delivery to retinal pigment epithelial cells.
    • 162
    • Open Access